People · Operator
Named in public records as an officer, director or promoter · active 2017–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Deep Blue Medical Advances, Inc. | — | Biotechnology | Series A | $18.1M | $15.5M | 2025 |
| Breathe Technologies, Inc. | — | Biotechnology | Series A | $14.8M | $225.9M | 2017 |
Neil Meyer at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Neil Meyer on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Beth Seidenberg | 1 | 15 |
| Steven Hochberg | 1 | 9 |
| John Miclot | 1 | 5 |
| Ken Gall | 1 | 4 |
| Robert Bonczek | 1 | 3 |
| William Perry | 1 | 3 |
| Lawrence Mastrovich | 1 | 3 |
| Michael Bates | 1 | 3 |
| Ted Huber | 1 | 2 |
| Bruce Steel | 1 | 2 |
| Steve Hochberg | 1 | 2 |
| Brent Duncan | 1 | 2 |
| Robert Isaacs | 1 | 2 |
| Gary Berman | 1 | 2 |
| John Spilman | 1 | 2 |
| Samir Ahmad | 1 | 1 |
| Howard Levinson | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.